Literature DB >> 34493665

Prediction of arrhythmia susceptibility through mathematical modeling and machine learning.

Meera Varshneya1, Xueyan Mei2, Eric A Sobie3.   

Abstract

At present, the QT interval on the electrocardiographic (ECG) waveform is the most common metric for assessing an individual's susceptibility to ventricular arrhythmias, with a long QT, or, at the cellular level, a long action potential duration (APD) considered high risk. However, the limitations of this simple approach have long been recognized. Here, we sought to improve prediction of arrhythmia susceptibility by combining mechanistic mathematical modeling with machine learning (ML). Simulations with a model of the ventricular myocyte were performed to develop a large heterogenous population of cardiomyocytes (n = 10,586), and we tested each variant's ability to withstand three arrhythmogenic triggers: 1) block of the rapid delayed rectifier potassium current (IKr Block), 2) augmentation of the L-type calcium current (ICaL Increase), and 3) injection of inward current (Current Injection). Eight ML algorithms were trained to predict, based on simulated AP features in preperturbed cells, whether each cell would develop arrhythmic dynamics in response to each trigger. We found that APD can accurately predict how cells respond to the simple Current Injection trigger but cannot effectively predict the response to IKr Block or ICaL Increase. ML predictive performance could be improved by incorporating additional AP features and simulations of additional experimental protocols. Importantly, we discovered that the most relevant features and experimental protocols were trigger specific, which shed light on the mechanisms that promoted arrhythmia formation in response to the triggers. Overall, our quantitative approach provides a means to understand and predict differences between individuals in arrhythmia susceptibility.

Entities:  

Keywords:  arrhythmias; electrophysiology; machine learning; mathematical modeling; population modeling

Mesh:

Substances:

Year:  2021        PMID: 34493665      PMCID: PMC8449417          DOI: 10.1073/pnas.2104019118

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  50 in total

1.  Parameter sensitivity analysis in electrophysiological models using multivariable regression.

Authors:  Eric A Sobie
Journal:  Biophys J       Date:  2009-02-18       Impact factor: 4.033

Review 2.  Refining detection of drug-induced proarrhythmia: QT interval and TRIaD.

Authors:  Rashmi R Shah; Luc M Hondeghem
Journal:  Heart Rhythm       Date:  2005-07       Impact factor: 6.343

3.  Artificial intelligence-enabled rapid diagnosis of patients with COVID-19.

Authors:  Xueyan Mei; Hao-Chih Lee; Kai-Yue Diao; Mingqian Huang; Bin Lin; Chenyu Liu; Zongyu Xie; Yixuan Ma; Philip M Robson; Michael Chung; Adam Bernheim; Venkatesh Mani; Claudia Calcagno; Kunwei Li; Shaolin Li; Hong Shan; Jian Lv; Tongtong Zhao; Junli Xia; Qihua Long; Sharon Steinberger; Adam Jacobi; Timothy Deyer; Marta Luksza; Fang Liu; Brent P Little; Zahi A Fayad; Yang Yang
Journal:  Nat Med       Date:  2020-05-19       Impact factor: 53.440

Review 4.  Opening the Black Box: Interpretable Machine Learning for Geneticists.

Authors:  Christina B Azodi; Jiliang Tang; Shin-Han Shiu
Journal:  Trends Genet       Date:  2020-04-17       Impact factor: 11.639

Review 5.  Assessing predictors of drug-induced torsade de pointes.

Authors:  Luiz Belardinelli; Charles Antzelevitch; Marc A Vos
Journal:  Trends Pharmacol Sci       Date:  2003-12       Impact factor: 14.819

6.  Comprehensive analyses of ventricular myocyte models identify targets exhibiting favorable rate dependence.

Authors:  Megan A Cummins; Pavan J Dalal; Marco Bugana; Stefano Severi; Eric A Sobie
Journal:  PLoS Comput Biol       Date:  2014-03-27       Impact factor: 4.475

7.  Novel Two-Step Classifier for Torsades de Pointes Risk Stratification from Direct Features.

Authors:  Jaimit Parikh; Viatcheslav Gurev; John J Rice
Journal:  Front Pharmacol       Date:  2017-11-14       Impact factor: 5.810

8.  General Principles for the Validation of Proarrhythmia Risk Prediction Models: An Extension of the CiPA In Silico Strategy.

Authors:  Zhihua Li; Gary R Mirams; Takashi Yoshinaga; Bradley J Ridder; Xiaomei Han; Janell E Chen; Norman L Stockbridge; Todd A Wisialowski; Bruce Damiano; Stefano Severi; Pierre Morissette; Peter R Kowey; Mark Holbrook; Godfrey Smith; Randall L Rasmusson; Michael Liu; Zhen Song; Zhilin Qu; Derek J Leishman; Jill Steidl-Nichols; Blanca Rodriguez; Alfonso Bueno-Orovio; Xin Zhou; Elisa Passini; Andrew G Edwards; Stefano Morotti; Haibo Ni; Eleonora Grandi; Colleen E Clancy; Jamie Vandenberg; Adam Hill; Mikiko Nakamura; Thomas Singer; Liudmila Polonchuk; Andrea Greiter-Wilke; Ken Wang; Stephane Nave; Aaron Fullerton; Eric A Sobie; Michelangelo Paci; Flora Musuamba Tshinanu; David G Strauss
Journal:  Clin Pharmacol Ther       Date:  2019-11-10       Impact factor: 6.903

Review 9.  A Heart for Diversity: Simulating Variability in Cardiac Arrhythmia Research.

Authors:  Haibo Ni; Stefano Morotti; Eleonora Grandi
Journal:  Front Physiol       Date:  2018-07-20       Impact factor: 4.566

10.  A Computational Pipeline to Predict Cardiotoxicity: From the Atom to the Rhythm.

Authors:  Pei-Chi Yang; Kevin R DeMarco; Parya Aghasafari; Mao-Tsuen Jeng; John R D Dawson; Slava Bekker; Sergei Y Noskov; Vladimir Yarov-Yarovoy; Igor Vorobyov; Colleen E Clancy
Journal:  Circ Res       Date:  2020-02-24       Impact factor: 17.367

View more
  1 in total

1.  Quantitative approaches to drug safety: The 2022 PSP special issue.

Authors:  Eric A Sobie
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2022-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.